You are here

  • Home
  • Archive
  • Volume 10, Issue 1
  • Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLE

Citation Tools

Article menu
Epidemiology and outcomes
Original research
Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLE

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Askanase AD, Tang W, Zuraw Q, et al
Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLE
Lupus Science & Medicine 2023;10:e000875. doi: 10.1136/lupus-2022-000875